2009 FLU Solicitation Amendment.doc

DOC document 89 KB Posted

Attached to
2009 Influenza Virus Vaccines
Solicitation number
2009-N-10994
Issued by

About this file

This Amendment to Solicitation 2009-N-10994 is to limit the Solicitation to vaccines for use in the VFC program only and to offer a revised Schedule/CLIN structure to be used in each proposal .

View the file

Other files

File Type Posted
Q A 2 for 2009 FLU Solicitation 2009-N-10994.doc DOC document
Q A for 2009 FLU Solicitation 2009-N-10994.doc DOC document
2009 FLU Solicitation.doc DOC document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT

1. CONTRACT ID CODE

PAGE OF PAGES

2. AMENDMENT/MODIFICATION NO.

00001

3. EFFECTIVE DATE

12/15/2008

4. REQUISITION/PURCHASE REQ. NO.

5. PROJECT NO. (If applicable)

6. ISSUED BY
CODE
2543
7. ADMINISTERED BY (If other than Item 6)
CODE
2543

FORMTEXT

Centers for Disease Control and Prevention CDC

Procurement and Grants Office (PGO)

2920 Brandywine Rd, MS K-14

Atlanta, GA 30341-5539

8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)

X

9A. AMENDMENT OF SOLICITATION NO.

2009-N-10994 9B. DATED (See Item 11) 12/15/2008

10A. MODIFICATION OF CONTRACT/ORDER NO.

10B. DATED (See Item 13)

CODE
FACILITY CODE

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

X The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:

(a) By completing Items 8 and 15, and returning 0 copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEGMENT

TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT

IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by telegram or letter, provided each telegram or letter makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

12. ACCOUNTING AND APPROPRIATION DATA (If required)

13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS,

IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

A.

THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN

B.

THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

C.

THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

D.

OTHER (Specify type of modification and authority)

E. IMPORTANT: Contractor

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

The purpose of this amendment is to limit this Solicitation 2009-N-10994 to vaccines for use in the VFC program only and to remove CLIN 0005 [Influenza Virus Vaccine, (Adult) (Age 18 years and older)] on the original solicitation. As result of removing the requirement for Influenza Virus Vaccine, (Adult) (Age 18 years and older), the attached schedule/Clin structure replaces the schedule/Clin structure that was in the original solicitation.

Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

15A. NAME AND TITLE OF SIGNER (Type or print)

16A. NAME OF CONTRACTING OFFICER

Edward J.Schultz

15B. CONTRACTOR/OFFEROR

(Signature of person authorized to sign)

15C. DATE SIGNED

16B. UNITED STATES OF AMERICA

BY ___________________________________________

(Signature of Contracting Officer)

16C. DATE SIGNED

12/15/2008

NSN 7540-01-152-8070

STANDARD FORM 30 (REV. 10-83)

PREVIOUS EDITION UNUSABLE

30-105 Prescribed by GSA

FAR (48 CFR) 53.243

CONTINUATION OF SF 1449tc \l2 "CONTINUATION OF SF 1449

Contract Line

Item No. (CLIN) Vaccine Description 0001 Pediatric Influenza Virus Vaccine (FDA approved for ages 6-35 months)

Preservative Free which contains trace amounts of Thimerosal

Maximum Estimated Quantity:

5,000,000 Doses

Guaranteed Minimum Quantity:

100 Doses

Product Requirements:

Minimum Shelf Life:

Expiration date of June 30, 2010 or later

Minimum Order Size:

300 Doses Per Destination

OBRA Ceiling Price:

Not Applicable

Federal Excise Tax:

$.75 Per Dose

Size Restriction:

Any vial size available, not to exceed 10 doses per vial

**pre-filled syringes shall not have fixed needles.**

Proposal Information:

Product/Brand Name:

Proposed Quantities

Total Maximum:

Monthly Maximum:

In the space below or on a separate page, the offeror shall enter the following information for all package options offered: Vial/Package Size, NDC Number and Unit Price (excluding Federal Excise Tax):

Contract Line

Item No. (CLIN) Vaccine Description

Influenza Virus Vaccine (FDA approved for ages 6 months and older)

Maximum Estimated Quantity:

6,000,000 Doses

Guaranteed Minimum Quantity:

100 Doses

Product Requirements:

Minimum Shelf Life:

Expiration date of June 30, 2010 or later

Minimum Order Size:

300 Doses Per Destination

OBRA Ceiling Price:

Not Applicable

Federal Excise Tax:

$.75 Per Dose

Size Restriction:

Any vial size available, not to exceed 10 doses per vial

In the space below or on a separate page, the offeror shall enter the following information for all package options offered: Vial/Package Size, NDC Number and Unit Price (excluding Federal Excise Tax):

Contract Line

Item No. (CLIN) Vaccine Description

Influenza Virus Vaccine, (FDA approved for ages 36 months and older)

Maximum Estimated Quantity:

3,000,000 Doses

Guaranteed Minimum Quantity:

100 Doses

Product Requirements:

Minimum Shelf Life:

Expiration date of June 30, 2010 or later

Minimum Order Size:

300 Doses Per Destination

OBRA Ceiling Price:

Not Applicable

Federal Excise Tax:

$.75 Per Dose

Size Restriction:

Any vial size available, not to exceed 10 doses per vial

In the space below or on a separate page, the offeror shall enter the following information for all package options offered: Vial/Package Size, NDC Number and Unit Price (excluding Federal Excise Tax):

Contract Line

Item No. (CLIN) Vaccine Description

Influenza Virus Vaccine, (FDA approved for ages 4 years and older)

Maximum Estimated Quantity:

3,000,000 Doses

Guaranteed Minimum Quantity:

100 Doses

Product Requirements:

Minimum Shelf Life:

Expiration date of June 30, 2010 or later

Minimum Order Size:

300 Doses Per Destination

OBRA Ceiling Price:

Not Applicable

Federal Excise Tax:

$.75 Per Dose

Size Restriction:

Any vial size available, not to exceed 10 doses per vial

In the space below or on a separate page, the offeror shall enter the following information for all package options offered: Vial/Package Size, NDC Number and Unit Price (excluding Federal Excise Tax):

Contract Line

Item No. (CLIN) Vaccine Description

Influenza Virus Vaccine – Live Intranasal –

Preservative Free (FDA approved for ages 2 – 49 years) Maximum Estimated Quantity:

4,000,000 Doses

Guaranteed Minimum Quantity:

100 Doses

Product Requirements:

Minimum Shelf Life:

Expiration date of June 30, 2010 or later

Minimum Order Size:

20 Doses Per Destination

OBRA Ceiling Price:

Not Applicable

Federal Excise Tax:

$.75 Per Dose

Size Restriction:

Any vial size available

In the space below or on a separate page, the offeror shall enter the following information for all package options offered: Vial/Package Size, NDC Number and Unit Price (excluding Federal Excise Tax):

Contract Line

Item No. (CLIN) Vaccine Description

Influenza Virus Vaccine, (Optional Product)

Contractor may use this CLIN to propose any vaccine pending FDA approval to be added to this contract as an optional product. This CLIN may be exercised at the discretion of the Government upon FDA approval.

Maximum Estimated Quantity:

(to be proposed) Doses

Guaranteed Minimum Quantity:

0 Doses

Product Requirements:

Minimum Shelf Life:

Expiration date of June 30, 2010 or later

Minimum Order Size:

30 Doses Per Destination

OBRA Ceiling Price:

Not Applicable

Federal Excise Tax:

$.75 Per Dose

Size Restriction:

Any vial size available, not to exceed 10 doses per vial

In the space below or on a separate page, the offeror shall enter the following information for all package options offered: Vial/Package Size, NDC Number and Unit Price (excluding Federal Excise Tax):

ITEM 10A.

File details come from the government source that posted it. Updated .